MeiraGTx Holdings (MGTX) Total Current Liabilities (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Total Current Liabilities of $283000.0 for Q4 2025, down 99.81% on a QoQ basis from $152.9 million in Q3 2025, and down 68.66% year-over-year from $903000.0 in Q4 2024.
MeiraGTx Holdings (MGTX) Total Current Liabilities (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Total Current Liabilities history runs 9 years deep, the most recent figure standing at $283000.0 for Q4 2025.
- Quarterly Total Current Liabilities fell 68.66% year-over-year to $283000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $283000.0 (down 68.66% YoY) and the FY2025 annual result came in at $283000.0, down 68.66% from the prior year.
- Total Current Liabilities was $283000.0 for Q4 2025 at MeiraGTx Holdings, down from $152.9 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $152.9 million in Q3 2025 and bottomed at $283000.0 in Q4 2025.
- A 5-year average of $61.2 million and a median of $61.6 million in 2021 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Current Liabilities slumped 98.65% — and 2025, when it soared 157.37%.
- MeiraGTx Holdings' Total Current Liabilities stood at $68.1 million in 2021, then advanced by 20.47% to $82.1 million in 2022, then dropped by 18.27% to $67.1 million in 2023, then slumped by 98.65% to $903000.0 in 2024, then sank by 68.66% to $283000.0 in 2025.
- Business Quant data shows MGTX's Total Current Liabilities at $283000.0 in Q4 2025, $152.9 million in Q3 2025, and $53.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 283,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 283,000.00 |
| Sep 30, 2025 | 152.92 Mn |
| Jun 30, 2025 | 53.44 Mn |
| Mar 31, 2025 | 52.37 Mn |
| Dec 31, 2024 | 903,000.00 |
| Sep 30, 2024 | 59.42 Mn |
| Jun 30, 2024 | 47.01 Mn |
| Mar 31, 2024 | 47.54 Mn |
| Dec 31, 2023 | 67.08 Mn |
| Sep 30, 2023 | 63.51 Mn |
| Jun 30, 2023 | 71.80 Mn |
| Mar 31, 2023 | 81.10 Mn |
| Dec 31, 2022 | 82.07 Mn |
| Sep 30, 2022 | 72.36 Mn |
| Jun 30, 2022 | 67.51 Mn |
| Mar 31, 2022 | 65.50 Mn |
| Dec 31, 2021 | 68.13 Mn |
| Sep 30, 2021 | 59.63 Mn |
| Jun 30, 2021 | 57.25 Mn |
| Mar 31, 2021 | 53.52 Mn |